To face the challenges posed by the scale-up of nanomedicines, practical experimental designs could provide efficient solutions.Once scale-up is achieved, nanomedicines will be made better available in the market for the treatment of a myriad of diseases."
No takes yet. Share an insight, caveat, or question.
Muthu et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: